Haemonetics (HAE) Income from Continuing Operations (2009 - 2026)

Haemonetics' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 20121000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 134.7% year-over-year to 20121000.0; the TTM figure through Mar 2026 stood at 97370000.0 (down 41.94% YoY), while the FY2026 annual figure was 97308000.0, down 41.97% from the prior year.
• Income from Continuing Operations was 20121000.0 for Q1 2026 at Haemonetics, down from 44775000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 57981000.0 in Q1 2025 to a low of 20121000.0 in Q1 2026.
• Historically, Income from Continuing Operations has averaged 29509000.0 across 5 years, with a median of 33070500.0 in 2022.
• The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations jumped 546.27% in 2022, then slumped 134.7% in 2026.
• A 5-year view of Income from Continuing Operations shows it stood at 32944000.0 in 2022, then retreated by 5.17% to 31241000.0 in 2023, then gained by 20.02% to 37494000.0 in 2024, then gained by 19.42% to 44775000.0 in 2025, then slumped by 144.94% to 20121000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 20121000.0 (Q1 2026), 44775000.0 (Q4 2025), and 38685000.0 (Q3 2025), per Business Quant data.